Using deep brain stimulation to treat severe addiction
Official title: HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use Disorders
Run by Centre for Addiction and Mental Health · NCT06973512 · Data updated 2026-11-12
This study is testing if deep brain stimulation can help people with severe addiction who haven't found success with other treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 65 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT06973512 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 25-65 with severe substance use disorders who have not responded to at least two evidence-based treatment modalities.
✕Probably not a fit
Patients with major medical co-morbidities or contraindications to neurosurgical interventions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The HABITS Study aims to explore the effectiveness of deep brain stimulation (DBS) for individuals suffering from treatment-refractory substance use disorders (SUD). This innovative approach utilizes stereoelectroencephalography (SEEG) to personalize the stimulation targets and settings for each patient, addressing the unique neural networks involved in addiction. By combining DBS with a comprehensive drug craving provocation paradigm and advanced AI analysis, the study seeks to improve treatment outcomes for those who have not responded to traditional therapies. The study is designed to be minimally invasive and reversible, with a focus on enhancing the precision of treatment.
Why it matters
Potential benefit: If successful, this study could provide a new, effective treatment option for individuals struggling with severe substance use disorders.
How similar studies have gone: Other studies have shown promise for deep brain stimulation in treating various conditions, but this specific application for substance use disorders is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult, Age 25-65 * Severe DSM-5 substance use disorder (SUD) as assessed by Structured Clinical Interview for DSM-5 (SCID-5) * Treatment refractory as evidenced by non-response to an adequate trial of ≥2 evidence-based treatment modalities for their substance use disorder in the most recent 3 years of illness, as determined by the study clinical team * Able to comply with study visit schedule and timeline * Stable housing and reliable transportation * Treatment-seeking (\>7 on a 0-10 readiness ruler and open to the end-of-treatment outcome of abstinence) * Capable of understanding and providing informed consent Exclusion Criteria: * Contraindications to neurosurgical interventions such as major medical co-morbidities, including uncontrolled hypertension, coagulopathy, severe diabetes, major organ system failure, active infection or history of implant-related infections, immunocompromised state, or malignancy with \<5 years life expectancy * Contraindications for MRI, including implanted metallic devices (e.g., non-MRI-safe cardiac pacemaker or neurostimulator; some artificial joints metal pins; surgical clips; or other implanted metal parts), or claustrophobia or discomfort in confined spaces * Cardiac pacemaker/defibrillator, or other implanted stimulator * Presence of epilepsy, stroke, or degenerative disorder of the nervous system * Serious problems with literacy, vision, or hearing
Where it's running
-
Centre for Addiction and Mental Health / Toronto Western Hospital
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Victor Addiction psychiatrist and scientist, MD, MSc
- Email: Victor.Tang@camh.ca
- Phone: 416-535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NLP-based weekly writings to track mood and worry during residential rehab for SUD
This study tests whether weekly Spanish narratives and biweekly questionnaires can reveal patterns of mood and thoughts that relate to recovery in adults with substance use disorders in a Mexican rehab center.
-
Vocal Signals of Craving in Addiction
Researchers will see if voice patterns can signal craving in adults with addictions by having them perform voice tasks and report their cravings in real time.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
Real-time fMRI Neurofeedback for Anhedonia in Methadone-Treated Opioid Use Disorder
This feasibility study tests a real-time fMRI neurofeedback approach to see if it helps reduce anhedonia in people on methadone for opioid use disorder.
-
Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy
This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.
-
Connecting Loved Ones to Support and Empower Recovery
A web-based program called KulaMind-Recovery tests whether guided online training, one-on-one coaching, and a community forum help loved ones support someone with a substance use disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.